Sun Tingting, Wu Hao, Liu Jing, Jiang Lin, Wang Xinyu, Xu Fei, Li Xiubo
National Feed Drug Reference Laboratories, Institute of Feed Research, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Poult Sci. 2025 Feb;104(2):104685. doi: 10.1016/j.psj.2024.104685. Epub 2024 Dec 17.
The poultry red mite (PRM), Dermanyssus gallinae, a significant ectoparasite causing diseases in poultry, is globally prevalent and necessitates effective control strategies. There are restrictions on the use of acaricides in poultry across several nations due to worries about medication residues. Consequently, finding safe and efficient treatments for PRM is imperative. Fluralaner solution has emerged as a potential therapeutic agent, distinguished by its rapid onset, enduring efficacy, and lack of a withdrawal period for egg production. To ascertain the optimal dosage and therapeutic efficacy of fluralaner solution in PRM treatment, this study evaluated blood biochemical parameters and mite populations across various treatment groups. A cohort of 500 laying hens was randomly assigned to one of five treatment groups, each comprising 100 individuals:high-dose group (0.1 ml/kg-bw, group 4 ×, coop 1), medium-dose group (0.05 ml/kg-bw, group 2 ×, coop 5), low-dose group (0.025 ml/kg-bw, group 1 ×, coop 2), drug-control group (Intervet Productions, 0.05 ml/kg-bw recommended dose, coop 3) and blank control group (coop 4). Hens received their respective dosages of the fluralaner solution via oral administration on Days 0 (D0) and 7 (D7) of the experimental period. Over the study's ninety days, blood biochemical markers and mite counts in each coop were measured to evaluate the drug's safety, effectiveness, and ideal dosage. Data analysis was performed utilizing SPSS software. The study findings indicated that, for effective PRM infestation treatment, a dosage of 0.5 mg fluralaner per kilogram of body weight (equivalent to 0.05 ml) administered daily, followed by a subsequent dose post a 7-day interval, is recommended. Additionally, clinical observations coupled with blood biochemical assessments confirmed the safety of fluralaner across the three tested dosage levels in hens.
鸡皮刺螨(PRM),即鸡皮刺螨(Dermanyssus gallinae),是一种在家禽中引发疾病的重要体外寄生虫,在全球范围内广泛存在,因此需要有效的控制策略。由于担心药物残留,多个国家对家禽使用杀螨剂都有限制。因此,寻找安全有效的鸡皮刺螨治疗方法势在必行。氟虫腈溶液已成为一种潜在的治疗药物,其特点是起效迅速、疗效持久,且产蛋无需停药期。为确定氟虫腈溶液治疗鸡皮刺螨的最佳剂量和治疗效果,本研究评估了不同治疗组的血液生化参数和螨虫数量。将500只产蛋母鸡随机分为五个治疗组之一,每组100只:高剂量组(0.1毫升/千克体重,4倍剂量组,鸡舍1)、中剂量组(0.05毫升/千克体重,2倍剂量组,鸡舍5)、低剂量组(0.025毫升/千克体重,1倍剂量组,鸡舍2)、药物对照组(英特威生产,0.05毫升/千克体重推荐剂量,鸡舍3)和空白对照组(鸡舍4)。在实验期的第0天(D0)和第7天(D7),母鸡通过口服接受各自剂量的氟虫腈溶液。在研究的90天内,测量每个鸡舍的血液生化指标和螨虫数量,以评估药物的安全性、有效性和理想剂量。使用SPSS软件进行数据分析。研究结果表明,为有效治疗鸡皮刺螨感染,建议每日每千克体重施用0.5毫克氟虫腈(相当于0.05毫升),7天后再施用后续剂量。此外,临床观察和血液生化评估证实了氟虫腈在三个测试剂量水平下对母鸡的安全性。